Recent News

• 02.19.2025 - KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
• 02.06.2025 - KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System
• 01.30.2025 - KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology
• 01.13.2025 - KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter
• 11.25.2024 - KORU Medical Systems to Participate in Piper Sandler’s 36th Annual Healthcare Conference
• 11.13.2024 - KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Recent Filings

• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.21.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 01.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.13.2025 - 8-K Current report
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.03.2025 - 4 Statement of changes in beneficial ownership of securities